Subscribe

Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 5/1/24: Tailoring AI Regulation in Healthcare, OpenAI and Microsoft Sued Over AI & more

ByMiranda Schmalfuhs

May 1st 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/30/24: Advocating For Weight Loss Medication, AI Start-Ups Face Rough Financial Reality Check & more

ByMiranda Schmalfuhs

April 30th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/29/24: Going Beyond Visuals to Connect with Diverse Audiences, Invensify Introduces Energy Efficient Cold Chain Shipping Transporter & more

ByMiranda Schmalfuhs

April 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/26/24: Amazon Introduces Custom AI Capabilities, Crafting Culturally Sensitive Messages to Reach Diverse Audience & more

ByMiranda Schmalfuhs

April 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

ByMiranda Schmalfuhs

April 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

ByMiranda Schmalfuhs

April 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/23/24: Meta Places Smart Assistants Across Its Apps, Burden of Pneumococcal Disease Consistent Across Age Groups & more

ByMiranda Schmalfuhs

April 23rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more

ByMiranda Schmalfuhs

April 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

ByMiranda Schmalfuhs

April 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/18/24: Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more

ByMiranda Schmalfuhs

April 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

ByMiranda Schmalfuhs

April 17th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

ByMiranda Schmalfuhs

April 16th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more

ByMiranda Schmalfuhs

April 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

ByMiranda Schmalfuhs

April 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

ByMiranda Schmalfuhs

April 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

ByMiranda Schmalfuhs

April 10th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/9/24: AI in Clinical Development, Patient Preferences Play Essential Part in Contraceptive Care & more

ByMiranda Schmalfuhs

April 9th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more

ByMiranda Schmalfuhs

April 8th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

ByMiranda Schmalfuhs

April 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more

ByMiranda Schmalfuhs

April 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more

ByMiranda Schmalfuhs

April 3rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more

ByMiranda Schmalfuhs

April 2nd 2024

The latest news for pharma industry insiders.

Digital Solutions & Disruptive Technologies Transforming the Future Landscape of Biopharma Manufacturing

ByMiranda Schmalfuhs

April 1st 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses what innovative digital solutions and disruptive technologies he sees transforming the landscape of biopharma manufacturing in the future.

Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more

ByMiranda Schmalfuhs

April 1st 2024

The latest news for pharma industry insiders.

The Rising Tide of Biopharma Manufacturing Costs

ByMiranda Schmalfuhs

March 29th 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses the specific factors contributing to rising manufacturing costs.

Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more

ByMiranda Schmalfuhs

March 29th 2024

The latest news for pharma industry insiders.

Reducing Costs and Increasing Accessibility of ADCs & Cell and Gene Therapies

ByMiranda Schmalfuhs

March 28th 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses what digital tools, beyond AI and ML, hold the most promise for reducing costs and increasing accessibility of treatments.

Pharma Pulse 3/28/24: Do Mixed Results Impact Potential Real-World Effectiveness? FDA Issues Letters Over Unapproved, Misbranded OTC Analgesic Products & more

ByMiranda Schmalfuhs

March 28th 2024

The latest news for pharma industry insiders.

Leveraging Digital Tools to Optimize Manufacturing Processes

ByMiranda Schmalfuhs

March 27th 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses how companies can leverage digital tools like artificial intelligence and machine learning to optimize manufacturing processes and ensure efficient production.

Pharma Pulse 3/27/24: What's the ROI on GenAI? Virtual Second Opinions Save Over $8,700 Per Patient & more

ByMiranda Schmalfuhs

March 27th 2024

The latest news for pharma industry insiders.

© 2025 MJH Life Sciences^®

All rights reserved.